Preeclampsia (PE) is a serious public health problem for mothers, as it is estimated that 8-22% of pregnancies worldwide suffer from preeclampsia and 800 maternal deaths are attributed to PE (1.2).

Adipokine, adiponectin, leptin, obesity, preeclampsia.

Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33: 130-137.

Syndal S. Major Changes in Diagnosis and Man- agement of Preeclampsia. J Midwifery Womens Health 2015; 60: 226-226.Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gy- necol 2020; 135: e237-e260.

Roberts JM, Hubel CA. The Two Stage Model of Preeclampsia: Variations on the Theme. Placen- ta 2009; 30: S32-S37.

Redman CW, Sargent IL, Staff AC. IFPA Senior Award Lecture: making sense of pre-eclampsia – two placental causes of preeclampsia? Placenta 2014; 35: S20-S25.

Wang A, Ranam S, Karumanchi SA. Pre- eclampsia: The Role of Angiogenic Factors in Its Pathogenesis. Physiology 2009; 24: 147-158.

Pribadi A. Doppler: penggunaan praktis pada ob- stetri (Doppler: practical use in obstetrics). Ma- ternal-Fetal Division of Obstetrics and Gynecolo- gy, Faculty of Medicine University of Padjadjaran Bandung. 2017.

Roberts JM, Escudero C. The placenta in pre- eclampsia. Pregnancy Hypertens 2012; 2: 72-83.

Parrettini S, Caroli A, Torlone E. Nutrition and Metabolic Adaptations in Physiological and Com- plicated Pregnancy: Focus on Obesity and Ges- tational Diabetes. Front Endocrinol (Lausanne) 2020; 11: 611929.

Enquobahrie DA, Williams MA, Butler CL, Fred- erick IO, Miller RS, Luthy LA. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia. Am J Hypertens 2004; 17: 574-581.

Wang Y, Walsh SW, Kay HH. Placental tissue lev- els of nonesterified polyunsaturated fatty acids in normal and preeclamptic pregnancies. Hypertens Pregnancy 2005; 24: 235-245.

Li X, Huang Y, Zhang W, Yang C, Su W, Wu Y, Chen X, Zhou A, Huo X, Xia W, Xu S, Chen D, Li Y. Association of circulating saturated fatty ac- ids with the risk of pregnancy-induced hyperten- sion: a nested case–control study. Hypertens Res 2020; 43: 412-421.

Sudjai D. Association of pre-pregnancy body mass index with early- and late-onset severe pre- eclampsia. Eur J Obstet Gynecol Reprod Biol X 2023; 19: 100223.

Miller GJ. Dietary fatty acids and blood coagula- tion. Prostaglandins Leukot Essent Fatty Acids 1997; 57: 389-394.

Dusse LM, Rios DRA, Pinheiro MB, Cooper AJ, Waleed BA. Preeclampsia: relationship between coagulation, fibrinolysis and inflammation. Clin Chim Acta 2011; 412: 17-21.

Schwingshackl L, Hoffmann G. Monounsaturat- ed fatty acids and risk of cardiovascular disease: synopsis of the evidence available from system- atic reviews and meta-analyses. Nutrients 2012; 4: 1989-2007.

Putri M, Hamijoyo L, Alita VR, Atik N, Syamsuna- rno MRA. Very long fatty acid fractionation in sys-

temic lupus erythematosus in the active and inac- tive status. Int J Appl Pharm 2020; 12: 83-86.

Herrera E. Metabolic adaptations in pregnancy and their implications for the availability of sub- strates to the fetus. Eur J Clin Nutr 2000; 54: S47-S51.

Chandrasekaran S, Hunt H, Melhorn S, Gammill HS, Schur EA. Adipokine profiles in preeclampsia. J Matern Fetal Neonatal Med 2020; 33: 2812-2817.

Huda SS, Jordan F, Bray J, Love G, Payne R, Sat- tar N, Freeman DJ. Visceral adipose tissue acti- vated macrophage content and inflammatory adi- pokine secretion are higher in pre-eclampsia than in healthy pregnancys. Clin Sci (Lond) 2017; 131: 1529-1540.

Thagaard IN, Hedley PL, Holm JC, Lange T, Lars- en T, Krebs L, Christiansen M. Leptin and Adi- ponectin as markers for preeclampsia in obese pregnant women, a cohort study. Pregnancy Hy- pertens 2019; 15: 78-83.

Robinson NJ, Minchell LJ, Mys JE, Hubel CA, Crocker IP. A potential role for free fatty acids in the pathogenesis of preeclampsia. J Hypertens 2009; 27: 1293-1302.

Herlambang H, Puspasari A, Maharani C, Enis RN, Tarawifa S, Fitri AD, Harahap H, Harahap AH, Kusdiyah E, Syamsunarno MRAA. Compre- hensive fatty acid fractionation profilling in pre- eclampsia: a case control study with multivari- able analysis. BMC Pregnancy Childbirth 2022; 22: 8.

Zorena K, Jachimowicz-Duda O, Ślęzak D, Ro- bakowska M, Mrugacz M. Adipokines and Obe- sity. Potential Link to Metabolic Disorders and Chronic Complications. Int J Mol Sci 2020; 21: 3570.

Lopez-Jaramillo P, Barajas J, Rueda-Quijano SM, Lopez-Lopez C, Felix C. Obesity and Preeclamp- sia: Common Pathophysiological Mechanisms. Front Physiol 2018; 9: 1838.

Kirichenko TV, Markina YV, Bogatyreva AI, Tols- tik TV, Varaeva YR, Starodubova AV. The Role of Adipokines in Inflammatory Mechanisms of Obe- sity. Int J Mol Sci 2022; 23: 14982.

Frühbeck G, Catalán V, Rodríguez A, Gómez-Am- brosi J. Adiponectin-leptin ratio: A promising in- dex to estimate adipose tissue dysfunction. Rela- tion with obesity-associated cardiometabolic risk. Adipocyte 2018; 7: 57-62.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tet- zlaff JM, Akl EA, Brennan SE, Chou R, Glan- ville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for report- ing systematic reviews. BMJ 2021; 372: 71.

Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.Riley RD, Moons KGM, Snell KIE, Ensor J, Hooft L, Altman DG, Hayden J, Collins GS, Debray TPA. A guide to systematic review and meta-anal- ysis of prognostic factor studies. BMJ 2019; 364: k4597.

Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Contour-enhanced meta- analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol 2008; 61: 991-996.

Gómez-Hernández A, Beneit N, Díaz-Castro- verde S, Escribano Ó. Differential Role of Adi- pose Tissues in Obesity and Related Metabol- ic and Vascular Complications. Int J Endocrinol 2016; 2016: 1216783.

Malaguarnera M, Vacante M, Russo C, Malaguarnera G, Antic T, Malaguarnera L, Bel- la R, Pennisi G, Galvano F, Frigiola A. Lipopro- tein(a) in Cardiovascular Diseases. BioMed Res Int 2013; 2013: 650989.

Jachimowicz-Duda O, Wąż P, Zorena K. Interleu- kin-34 concentration is dependent on LDL cho- lesterol, HbA1c, CRP and WHR in patients with type 2 diabetes; Proceedings of the Crossroads of Lipid Metabolism and Diabetes 2015; Copen- hagen, Denmark 2015; 52.

Zorena K, Jachimowicz-Duda O, Wąż P. The cut- off value for interleukin 34 as an additional po- tential inflammatory biomarker for the prediction of the risk of diabetic complications. Biomarkers 2016; 21: 1-7.

Malin SK, Kirwan JP, Sia CL, González F. Pan- creatic β-cell dysfunction in polycystic ovary syndrome: Role of hyperglycemia-induced nu- clear factor-κB activation and systemic inflam- mation. Am J Physiol Metab 2015; 308: 770-777.

Daniele G, Guardado Mendoza R, Winnier D, Fiorentino TV, Pengou Z, Cornell J, Andreozzi F, Jenkinson C, Cersosimo E, Federici M, Trip- athy D, Folli F. The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus. Acta Diabetol 2013; 51: 123-

Tomić M, Ljubić S, Kaštelan S, Gverović Antu- nica A, Jazbec A, Poljičanin T. Inflammation, Haemostatic Disturbance, and Obesity: Possi- ble Link to Pathogenesis of Diabetic Retinopathy in Type 2 Diabetes. Mediat Inflamm 2013; 2013: 818671.

Zeng Z, Liu F, Li S. Metabolic adaptations in pregnancy: a review. Ann Nutr Metab 2017; 70: 59-65.

Shankar K, Hwang K, Westcott JL, Saleem S, Ali SA, Jessani S, Patel A, Kavi A, Somannavar MS, Goudar SS, Hibberd PL, Derman RJ, Hoffman M, Wylie BJ, Goldenberg RL, Thorsten VR, Mc- Clure EM, Krebs NF. Relative impact of pre-ec- lampsia on birth weight in a low resource setting: A prospective cohort study. Pregnancy Hypertens 2020; 21: 1-6.

Pruszyńska-Oszmałek E, Wojciechowska M, Krauss H, Sassek M, Leciejewska N, Szcze- pankiewicz D, Nowak KW, Piątek J, Nogowski L, Sliwowska JH, Kołodziejski PA. Obesity is associ- ated with increased level of kisspeptin in mothers’ blood and umbilical cord blood - a pilot study. Eur Rev Med Pharmacol Sci 2021; 25: 5993-6002.

Backes CH, Markham K, Moorehead P, Corde- ro L, Nankervis CA, Giannone PJ. Maternal Pre- eclampsia and Neonatal Outcomes. J Pregnancy 2011; 2011: 214365.

Mumbare SS, Maindarkar G, Darade R, Yenge S, Tolani MK, Patole K. Maternal risk factors as- sociated with term low birth weight neonates: a matched-pair case control study. Indian Pediatr 2012; 49: 25-28.